Diseases of the Central nervous system of various origins, especially those associated with vascular diseases and disorders of metabolic processes in the brain, which are accompanied by a deterioration of intellectual and mnestic functions, a decrease in motor activity. Neurotic States that are manifested by lethargy, increased exhaustion, decreased psychomotor activity, impaired attention, memory impairment, and decreased assimilation of information. Mild to moderate depression. Psychoorganic syndromes that manifest themselves as intellectual-mnestic disorders and apathetic-abulic phenomena, as well as sluggish-apathetic States in schizophrenia. Convulsive States. Prevention of hypoxia, increasing resistance to stress, correction of the functional state of the body in extreme conditions of professional activity in order to prevent the development of fatigue and improve mental and physical performance, correction of daily biorhythm, inversion of the sleep-Wake cycle. Chronic alcoholism (in order to reduce the phenomena of asthenia, depression, intellectual and mnestic disorders).
Out of stock
active substance: phenylpiracetam;
1 tablet contains phenylpiracetam 50 mg or 100 mg;
Entrop excipients: potato starch; lactose monohydrate; povidone; sodium starch glycolate (type A), calcium stearate.
Entrop Dosage form
Basic physical and chemical properties: flat-cylindrical tablets with a bevel from white to white with a cream shade of color.
Psychostimulants and nootropic drugs. ATX code N06B X.
Entrop® has a direct activating effect on the integrative activity of the brain, promotes memory consolidation, improves concentration and mental activity, facilitates learning, increases the resistance of brain tissues to hypoxia and toxic effects, has anticonvulsant and anxiolytic activity, and regulates active processes inhibition of the central nervous system, improves mood.
The drug has a positive effect on metabolic processes and blood circulation to the brain, stimulates redox processes, increases the body’s energy potential through glucose utilization, improves regional blood flow in ischemic areas of the brain. Increases the content of norepinephrine, dopamine and serotonin in the brain, does not affect the level of gamma-aminobutyric acid (GABA), does not bind to GABA or GABA receptors, does not significantly affect the spontaneous bioelectrical activity of the brain.
Entrop® has no effect on respiration and the cardiovascular system, has a mild diuretic effect, has anorexigenic activity in the course of use.
The stimulating effect of Entrop® is manifested in its ability to show a moderate effect on motor reactions, in increasing physical performance, in a pronounced antagonism of the cataleptic action of neuroleptics, as well as in weakening the soporific effect of ethanol and hexenal.
The psychostimulant effect of Entrop® prevails in the ideational sphere. Moderate psychostimulant effect of the drug is combined with anxiolytic activity, improves mood, has some analgesic effect, increasing the threshold of pain sensitivity.
Diseases of the central nervous system of various genesis, especially associated with vascular diseases and metabolic disorders in the brain, which are accompanied by deterioration of intellectual and mnestic functions, decreased motor activity.
Neurotic states manifested by lethargy, increased exhaustion, decreased psychomotor activity, impaired attention, memory impairment, decreased absorption of information.
Mild to moderate depression.
Psychoorganic syndromes manifested by intellectual and mnestic disorders and apathetic-abulic phenomena, as well as lethargic states in schizophrenia.
Prevention of hypoxia, increasing resistance to stress, correction of the functional state of the body in extreme conditions of professional activity to prevent the development of fatigue and increase mental and physical performance, correction of daily biorhythm, inversion of the cycle “sleep-wake”.
Chronic alcoholism (in order to reduce the phenomena of asthenia, depression, intellectual and mnestic disorders).
Hypersensitivity to the components of the drug.
Interaction with other medicinal products and other forms of interaction
May enhance the action of drugs that stimulate the central nervous system, antidepressants and nootropic drugs, enhances and prolongs the action of hypnotics, narcotics and antiparkinsonian drugs.